84 related articles for article (PubMed ID: 20516430)
21. Cladribine in the treatment of low-grade non-Hodgkin's lymphoma.
Piro LD
Semin Hematol; 1996 Jan; 33(1 Suppl 1):34-9. PubMed ID: 8714615
[No Abstract] [Full Text] [Related]
22. Talactoferrin alpha receives fast-track designation for the treatment of non-small cell lung cancer.
McBride D
ONS Connect; 2007 Jan; 22(1):14. PubMed ID: 17393636
[No Abstract] [Full Text] [Related]
23. [A must: evaluation of adjuvant chemotherapy in bronchogenic cancers by a randomized trial].
Depierre A; Chastang C; Lebeau B; Clavier J; Milleron B; Brambilla C; Quoix E; Lemarié E
Rev Pneumol Clin; 1992; 48(2):45-7. PubMed ID: 1329178
[No Abstract] [Full Text] [Related]
24. Rituximab in three children with relapsed/refractory B-cell acute lymphoblastic leukaemia/Burkitt non-Hodgkin's lymphoma.
de Vries MJ; Veerman AJ; Zwaan CM
Br J Haematol; 2004 May; 125(3):414-5. PubMed ID: 15086431
[No Abstract] [Full Text] [Related]
25. [First antibody in oncology continues on a successful course].
Papadopoulos DO
Krankenpfl J; 2004; 42(5-6):162-5. PubMed ID: 15527227
[No Abstract] [Full Text] [Related]
26. Second and third line treatment in non-small cell lung cancer.
Favaretto A; Pasello G; Magro C; Schettino C; Gridelli C
Crit Rev Oncol Hematol; 2009 Aug; 71(2):117-26. PubMed ID: 19249227
[TBL] [Abstract][Full Text] [Related]
27. [Non-small cell lung cancer: Remarkable developments].
Vignot S; Wislez M
Bull Cancer; 2015 Dec; 102(12):962-3. PubMed ID: 26597477
[No Abstract] [Full Text] [Related]
28. Ceritinib (Zykadia) for non-small cell lung cancer.
Med Lett Drugs Ther; 2014 Jul; 56(1447):62-3. PubMed ID: 25046419
[No Abstract] [Full Text] [Related]
29. New agents and approaches to the treatment of B-cell non-Hodgkin lymphoma.
Burton JD; Goldenberg DM
Expert Opin Emerg Drugs; 2010 Dec; 15(4):569-83. PubMed ID: 20828225
[TBL] [Abstract][Full Text] [Related]
30. Nivolumab (Opdivo) for metastatic melanoma and metastatic NSCLC.
Med Lett Drugs Ther; 2015 Jun; 57(1470):85-7, 94. PubMed ID: 26035747
[No Abstract] [Full Text] [Related]
31. A case of metastatic adamantinoma responding to treatment with pazopanib.
Cohen Y; Cohen JE; Zick A; Orevi M; Doviner V; Rubinstein R; Goldshmidt H; Peylan-Ramu N; Katz D
Acta Oncol; 2013 Aug; 52(6):1229-30. PubMed ID: 23461672
[No Abstract] [Full Text] [Related]
32. Users fear that lymphoma drugs will disappear.
Garber K
J Natl Cancer Inst; 2007 Apr; 99(7):498-9, 501. PubMed ID: 17405990
[No Abstract] [Full Text] [Related]
33. New drugs in non-small cell lung cancer.
Comella P;
Tumori; 2000; 86(5 Suppl 1):S47-50. PubMed ID: 11195295
[No Abstract] [Full Text] [Related]
34. Durvalumab lengthens survival in patients with NSCLC.
Venkatesan P
Lancet Respir Med; 2017 Nov; 5(11):850. PubMed ID: 28943343
[No Abstract] [Full Text] [Related]
35. Efficient generation of constrained block allocation sequences.
Salama I; Ivanova A; Qaqish B
Stat Med; 2008 Apr; 27(9):1421-8. PubMed ID: 17729381
[TBL] [Abstract][Full Text] [Related]
36. Placebo-controlled randomized study of hydrazine sulfate in lung cancer.
Kosty MP; Herndon JE; Green MR; McIntyre OR
J Clin Oncol; 1995 Jun; 13(6):1529-30. PubMed ID: 7751903
[No Abstract] [Full Text] [Related]
37. Oncology update.
Smart M
Oncol Nurs Forum; 2011 Nov; 38(6):739-40. PubMed ID: 22037336
[No Abstract] [Full Text] [Related]
38. How strong is the case for intensive cancer chemotherapy?
Tattersall MH; Tobias JS
Lancet; 1976 Nov; 2(7994):1071-2. PubMed ID: 62911
[No Abstract] [Full Text] [Related]
39. My life as a guinea pig.
Reno J
Newsweek; 2001 Aug; 138(6):42. PubMed ID: 11499275
[No Abstract] [Full Text] [Related]
40. Venetoclax active and safe in non-Hodgkin lymphoma.
Das M
Lancet Oncol; 2017 Mar; 18(3):e136. PubMed ID: 28139404
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
